301089 拓新药业
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--001,4511,451
投资性房地产0--0000
固定资产802,010-1.54%814,550497,386478,348479,786
在建工程43,969-1.65%44,705372,682331,031130,477
无形资产79,419-0.87%80,12081,82784,04284,261
商誉0--0000
其他非流动资产145,1652.98%140,970129,337121,952133,274
1,070,563-0.91%1,080,3451,081,2321,016,825829,250

流动资产
货币资金115,673-17.53%140,26469,234148,554307,092
应收账款45,462-22.41%58,59078,588151,67842,042
存货196,2938.08%181,612178,883204,111241,139
其他流动资产222,9819.05%204,485350,307317,827423,733
580,408-0.78%584,951677,012822,1701,014,006

流动负债
短期借款0--00040,034
应付票据33,628-11.43%37,96634,37242,16059,082
应付帐款75,755-5.36%80,04898,835110,38999,498
其他流动负债31,93714.24%27,95532,11741,964225,350
141,320-3.18%145,969165,325194,512423,963
流动资产净值439,0880.02%438,982511,688627,658590,042
资产总额减流动负债1,509,650-0.64%1,519,3271,592,9191,644,4821,419,292

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债34,752-1.13%35,15040,39941,21042,923
34,752-1.13%35,15040,39941,21042,923

总权益
    实收股本126,5450.00%126,545126,545126,545126,000
    储备项目1,348,354-0.68%1,357,6321,425,9761,476,7271,250,370
股东权益1,474,898-0.63%1,484,1771,552,5201,603,2721,376,370
非控股权益0--0000